Emerging evidence highlights c-Myc's critical effect on regulating the tumor microenvironment (TME), which includes multiple cell types, such as cancer-associated fibroblasts (CAFs), tumor-associated macrophages (TAMs), and vascular endothelial cells (VECs), among others [14-17]. The gene discussed is MYC; the disease is neoplasm.